National Cancer Institute; Notice of Closed Meeting, 35259 [05-11987]

Download as PDF Federal Register / Vol. 70, No. 116 / Friday, June 17, 2005 / Notices for food allergens and for gluten, and to identify the biological concepts and data needed to evaluate the scientific soundness of each approach. The draft report entitled ‘‘Approaches to Establish Thresholds for Major Food Allergens and for Gluten in Food’’ is the result of the working group’s deliberations. In the Federal Register of May 23, 2005 (70 FR 29528), FDA announced a meeting of the agency’s Food Advisory Committee (FAC) on July 13, 14, and 15, 2005. At this meeting, the FAC will be asked to evaluate the draft report entitled ‘‘Approaches to Establish Thresholds for Major Food Allergens and for Gluten in Food.’’ In particular, the FAC will advise FDA whether, in the committee’s view, the draft report is scientifically sound in its analyses and approaches and adequately considers available relevant data on food allergens and on gluten. In seeking the committee’s advice, FDA plans to pose a series of scientific questions. These questions will be posted on CFSAN’s Web site at https://www.cfsan.fda.gov/ ~lrd/vidtel.html on July 12, 2005. Members of the public who may wish to participate in the FAC meeting, by written submission or an oral presentation, should consult the meeting notice for information regarding such participation. In addition to the FAC proceedings, the agency believes it would be useful to receive public comments on the Threshold Working Group’s draft report. The draft report describes a number of areas in which the working group concluded that the body of scientific data relating to food allergen thresholds is incomplete. Accordingly, FDA requests that members of the public submit comments and any relevant scientific data and information, particularly data and information that can fill the data gaps identified in the draft report. II. Request for Comments and for Scientific Data and Information Interested persons should submit comments and scientific data and information to the Division of Dockets Management (see ADDRESSES). Three copies of all comments and scientific data and information are to be submitted. Individuals submitting written information or anyone submitting electronic comments may submit one copy. Submissions are to be identified with the docket number found in brackets in the heading of this document and may be accompanied by supporting information. Received submissions may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. VerDate jul<14>2003 17:59 Jun 16, 2005 Jkt 205001 Information submitted after the closing date will not be considered except by petition under 21 CFR 10.30. III. Electronic Access The draft report is available electronically at https:// www.cfsan.fda.gov/~dms/whalrgy.html. Dated: June 14, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 05–12041 Filed 6–15–05; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Empahsis Panel; Emerging Technologies for Cancer Research. Date: July 14–15, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Contact Person: Joyce C. Pegues, PhD; Scientific Review Administrator; Special Review Administrator; Special Review and Logistics Branch; Division of Extramural Activities; National Cancer Institute; 6116 Executive Blvd. 7149; Bethesda, MD 20892. 301/594–1286. peguesj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 35259 Dated: June 10, 2005. LaVerne Y. Springfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–11987 Filed 6–16–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Review of Training Applications (T32s). Date: July 11, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia, MD 21004. Contact Person: Charles Joyce, PhD, Review Branch, NHLBI, National Institutes of Health, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892, (301) 435–0288. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Myelodysplastic Syndrome (MDS): Seeking cure through discovery on pathogenesis and disease progression. Date: July 12–13, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia, MD 21004. Contact Person: Katherine M. Malinda, PhD, Scientific Review Administrator, Review Branch, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7198, Bethesda, MD 20892, (301) 435–0297 Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Cellular and Genetic Discovery Toward Curative Therapy in Myeloproliferative Disorders (MPD) Date: July 13, 2005. Time: 8 a.m. to 5 p.m. E:\FR\FM\17JNN1.SGM 17JNN1

Agencies

[Federal Register Volume 70, Number 116 (Friday, June 17, 2005)]
[Notices]
[Page 35259]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11987]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Empahsis 
Panel; Emerging Technologies for Cancer Research.
    Date: July 14-15, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Contact Person: Joyce C. Pegues, PhD; Scientific Review 
Administrator; Special Review Administrator; Special Review and 
Logistics Branch; Division of Extramural Activities; National Cancer 
Institute; 6116 Executive Blvd. 7149; Bethesda, MD 20892. 301/594-
1286. peguesj@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 10, 2005.
LaVerne Y. Springfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-11987 Filed 6-16-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.